DK639887A - Farmaceutiske praeparater - Google Patents

Farmaceutiske praeparater

Info

Publication number
DK639887A
DK639887A DK639887A DK639887A DK639887A DK 639887 A DK639887 A DK 639887A DK 639887 A DK639887 A DK 639887A DK 639887 A DK639887 A DK 639887A DK 639887 A DK639887 A DK 639887A
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
antihypertensive agent
hypertension
therapy
simultaneous
Prior art date
Application number
DK639887A
Other languages
English (en)
Other versions
DK639887D0 (da
Inventor
Robin Edwin Buckingham
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629234A external-priority patent/GB8629234D0/en
Priority claimed from GB868630926A external-priority patent/GB8630926D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of DK639887D0 publication Critical patent/DK639887D0/da
Publication of DK639887A publication Critical patent/DK639887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK639887A 1986-12-06 1987-12-04 Farmaceutiske praeparater DK639887A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629234A GB8629234D0 (en) 1986-12-06 1986-12-06 Pharmaceutical preparations
GB868630926A GB8630926D0 (en) 1986-12-24 1986-12-24 Pharmaceutical preparations

Publications (2)

Publication Number Publication Date
DK639887D0 DK639887D0 (da) 1987-12-04
DK639887A true DK639887A (da) 1988-06-07

Family

ID=26291661

Family Applications (1)

Application Number Title Priority Date Filing Date
DK639887A DK639887A (da) 1986-12-06 1987-12-04 Farmaceutiske praeparater

Country Status (11)

Country Link
EP (1) EP0271271B1 (da)
KR (1) KR880007081A (da)
AT (1) ATE71535T1 (da)
AU (1) AU607728B2 (da)
CA (1) CA1305420C (da)
DE (1) DE3776111D1 (da)
DK (1) DK639887A (da)
ES (1) ES2055709T3 (da)
GR (1) GR3003599T3 (da)
NZ (1) NZ222806A (da)
PT (1) PT86292B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
DE3915236A1 (de) * 1989-05-10 1990-11-15 Merck Patent Gmbh Pharmazeutische zubereitung
GB8915315D0 (en) * 1989-07-04 1989-08-23 Sandoz Ltd Pharmaceutical compositions for use against hypertension and congestive heart failure
EP0555681A1 (en) * 1992-02-13 1993-08-18 E.R. SQUIBB & SONS, INC. Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct
DK0673374T3 (da) * 1992-12-11 2000-07-31 Smithkline Beecham Corp Farmaceutisk præparat, der indeholder bicykliske forbindelsestyper

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment

Also Published As

Publication number Publication date
DE3776111D1 (de) 1992-02-27
ES2055709T3 (es) 1994-09-01
KR880007081A (ko) 1988-08-26
AU8209987A (en) 1988-06-09
ATE71535T1 (de) 1992-02-15
PT86292B (pt) 1990-11-07
NZ222806A (en) 1991-05-28
PT86292A (pt) 1988-01-01
EP0271271B1 (en) 1992-01-15
EP0271271A2 (en) 1988-06-15
EP0271271A3 (en) 1989-11-15
CA1305420C (en) 1992-07-21
GR3003599T3 (da) 1993-03-16
DK639887D0 (da) 1987-12-04
AU607728B2 (en) 1991-03-14

Similar Documents

Publication Publication Date Title
DK2689A (da) Farmaceutisk praeparat
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
PT83872A (de) Arzneimittel
EP0296622A3 (en) Derivatives of poly(diallyl-methylamine) and their use as cholesterol-lowering agents
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
IL92672A0 (en) Retroviral protease inhibitors,their preparation and pharmaceutical compositions containing them
DK639887A (da) Farmaceutiske praeparater
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
IS5390A (is) Bensoxazín og bensóþíazín afleiður og notkun þeirra í lyf
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
AU6180486A (en) Novel tissue plasminogen activator derivatives
DK284688D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler
ATE28188T1 (de) Antikonvulsive mittel.
AU580890B2 (en) P-acylaminobenzamides
ES8704903A1 (es) Un metodo para preparar 6-cloro-2-metil-1h-2,3,4,5-tetrahidro-3-benzazepen-n-oxido.
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator
DK163175C (da) Synergistisk farmaceutisk kombinationspraeparat af vaevs-plasminogenaktivator, t-pa, og oxypurinol
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
FI874823A (fi) Farmaceutisk komposition foer anvaendning mot hypertension och kongestiv hjaertinsufficiens.
AU608232C (en) Modified tissue plasminogen activator
IE893509L (en) Medicinal use of inhibitors of lysyl oxidase
BR1100888A (pt) Variantes de ativador de plasminogênios de tecido, composições e métodos de uso da mesma
AU7554687A (en) Modified tissue plasminogen activator

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment